The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Commodities And Pharma Push FTSE 100 Below 6,000

Tue, 22nd Sep 2015 16:11

LONDON (Alliance News) - Stocks in London ended down Tuesday, with commodities-related stocks and pharmaceutical shares dragging down the FTSE 100, which ended below the 6,000 line for the first time in nearly a month.

The blue-chip index closed down 2.8% at 5,935.84 points, with all its constituents in the red except for RSA Insurance, which ended up 0.6%, a day after its shares tumbled 21% because Zurich Insurance pulled out of talks to buy the company.

The mid-cap FTSE 250 index declined 2.2% to 16,529.98, while the AIM All-Share ended down 1.3% at 730.51. European major indices also finished lower, with the CAC 40 in Paris down 3.4% and the DAX 30 in Frankfurt off 3.8%.

Shares in China closed higher as the Hang Seng index ended up 0.2% and the Shanghai Composite up 0.9%, while the Japanese market remained closed for holiday until Thursday.

In the US, stocks were in the red at the London close. The Dow Jones Industrial Average was down 1.7%, the S&P 500 down 1.7% and the Nasdaq Composite down 2.1%.

The strength of the dollar since the US Federal Reserve on Thursday last week decided to keep US interest rates on hold is hurting the price of commodities such as gold, silver and oil. The yellow metal retreated Tuesday to USD1,125.72 an ounce, while silver was down at USD14.79 per ounce.

The pound was lower against the dollar Tuesday at the London close, standing at USD1.5366, having traded at USD1.5558 before the Fed decision last week.

As a result, London-listed mining and oil-related stocks took yet another hit on Tuesday, with miners' misery exacerbated by a series of downgrades in the sector by Credit Suisse.

Antofagasta, down 6.6%, was cut to Underperform from Neutral, while Anglo American, 6.1%, was downgraded to Neutral from Outperform. Mid-cap KAZ Minerals, down 25%, was cut to Neutral from Outperform.

Others such as BHP Billiton, down 4.2%, and Rio Tinto, down 3.5%, also ended among the biggest fallers. Glencore was the worst performer in the FTSE 100, down 9.6% at 107.53 pence, having touched a new all-time low of 99.59p, the first time its price has gone below 100.00p.

Oil also was under pressure Tuesday. At the London close, Brent oil prices were down at USD47.85 a barrel, coming off the level of USD50.31 prior to the Fed announcement, while West Texas Intermediate stood at USD45.62 a barrel, having traded at USD47.68 before the Fed decision.

Oil stocks finished lower, with BG Group down 3.0%, Royal Dutch Shell 'B' shares down 3.1% and BP down 2.5%.

Outside of the commodities sector, London-listed pharmaceutical companies were out of favour after US presidential candidate Hillary Clinton tweeted about "price gouging" in the specialty drug market.

On her official Twitter account Monday, Clinton cited a New York Times article which said the price of the Daraprim drug, which treats a life-threatening parasitic infection, soared to USD750 a tablet from USD13.50 a tablet overnight.

Clinton, the frontrunner for the Democratic nomination, tweeted "price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on". Clinton was scheduled to make the announcement in Des Moines, Iowa, at 2 pm local time Tuesday, which is 2000 BST.

Shire ended down 5.0%, AstraZeneca down 4.4% and GlaxoSmithKline down 3.1%. The FTSE 100 drug makers all have significant US sales.

Engineering company GKN also was amongst the biggest fallers, down 6.1%, amid worries about knock-on effects of the emissions cheating scandal engulfing German car maker Volkswagen, the largest customer of GKN's Driveline business.

Though UBS said that the impact on GKN is likely to be "trivial", shares in the engineer touched a low it hasn't seen since early 2013.

Meanwhile, Johnson Matthey, the platinum group metals company that makes emission control technologies, lost 8.0%

Supermarket chain J Sainsbury ended down 1.6% even though Kantar Worldpanel's grocery market survey said that it was the only big four UK supermarket to increase sales in the past 12 weeks, for the second consecutive period.

Sainsbury's sales rose 0.9% in the 12 weeks to September 13 to GBP4.01 billion from GBP3.97 billion in the same period a year earlier, as its market share stayed flat at 16.2%.

Sainsbury's blue-chip peers, whose sales Kantar said were lower, ended heavily in the red, with Tesco and Wm Morrison Supermarkets down 4.3% and 4.5%, respectively.

In the FTSE 250, IG Group Holdings led the mid-cap gainers, up 2.6% after it said its revenue increased substantially in the first quarter against a weak comparative, but said the volatile market conditions make it difficult to predict an outcome for the full year.

The spread betting and contracts-for-difference company, which gives retail traders access to financial markets, said it is trading in line with its expectations at present, with revenue in the first quarter to the end of August up 24% to GBP106.0 million, though it noted the same period last year was "particularly subdued".

Meanwhile, US-focused science and technology development and commercialisation company Allied Minds ended down 15%. Its shares dropped after New York-based hedge fund Kerrisdale Capital outlined the reasons for its short position in the London stock.

Kerrisdale said Allied Minds has "no objective evidence of commercial success" in its portfolio and said its review of the company's subsidiaries "indicates that they are developing products that are, at best, minor variations on existing alternatives, often in the face of significant competition and without plausible business models."

In the corporate calendar Wednesday, Smiths Group releases full-year results, United Utilities issues a trading statement, and Gresham House publishes half-year results. Meanwhile, Pan African Resources releases full-year results, while Highland Gold Mining and Styles&Wood Group publish half-year results.

In the economic calendar, China's Caixin manufacturing Purchasing Manager's Index is due at 0245 BST. Germany's manufacturing and services PMI are expected at 0830 BST, while the same for the eurozone are due at 0900 BST. European Central Bank President Mario Draghi speaks at the European Parliament in Brussels at 1400 BST.

In the US, Markit manufacturing PMI is due at 1445 BST, while Energy Information Administration crude oil stocks are at 1530 BST. Atlanta Federal Reserve President Dennis Lockhart speaks at 1730 BST before the Columbus Rotary Club in the state of Georgia.

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.